FIELD: medicine. SUBSTANCE: invention describes compounds of formula I: cyclo(A-B-C-D-Arg) wherein A is D-Val; B is L- or D-Phe; C is L-Asp, D-Asp of D-Asp (O-C1-C4-alkyl and D- Gly or Ala, at least two of amino acid residues being in D-form, and also salts thereof. Compounds act as integrine inhibitors and are useful for prophylaxis and treatment of diseases of blood circulation system and therapy of tumors. Present invention also describes method of preparing compounds of formula I, pharmaceutical compositions based on compounds and method of treatment of diseases associated with inhibiting integrine receptor ligand binding, using compounds of formula (I) in daily amount of 0.01-2 mg/body weight. EFFECT: more efficient treatment method. 7 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
CYCLOPEPTIDES, A METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEIR AND A METHOD OF THEIR PREPARING | 1994 |
|
RU2130030C1 |
CYCLOPEPTIDES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD OF ITS PREPARING | 1996 |
|
RU2157379C2 |
BIOTIN DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF THEIR PREPARING | 1996 |
|
RU2171807C2 |
CYCLIC INHIBITORS OF ADHESION | 1997 |
|
RU2184121C2 |
CYCLOPEPTIDES AND METHOD OF PREPARATION THEREOF | 1995 |
|
RU2151776C1 |
CYCLIC INHIBITORS OF ADHESION | 1993 |
|
RU2116081C1 |
COMPOSITIONS, CONTAINING CYCLIC PEPTIDES AND METHODS OF APPLYING THEREOF | 2009 |
|
RU2555357C2 |
CYCLIC AZAPEPTIDES WITH ANGIOGENIC EFFECT | 1998 |
|
RU2188205C2 |
CYCLOPEPTIDE DERIVATIVES | 1997 |
|
RU2202557C2 |
CYLLOPEPTIDE DERIVATIVES | 1996 |
|
RU2174520C2 |
Authors
Dates
1999-04-27—Published
1993-11-04—Filed